Scholars Central

Research articlePublished 22 Nov 2021

A Novel PD-L1 Nanobody Validates that Immune Cell Suppressed by Pd-L1 May Always Exist in the Body

Authors: Chuangfu Chen, Peng Wu, Jiao Jiao

Immunotherapy: Open Access

Volume 7 · Issue 5 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: PD-L1 is expressed widely in the body. PD-1-PD-L1 interaction is known to drive T cell dysfunction, which can be blocked by anti-PD-1/PD-L1 antibodies. Researchers have shown that blocking PD-L1 in both the early and chronic stages of the disease may increase T cell activity. What’s more, we tried to find the improvement of PD-L1 on the body's immunity. Methods: Nanobody binding to PD-L1 was prepared, and the PD-L1 nanobody was verified by SDS-PAGE and Western-Blot. Affinity detection of PD-L1 Nanobody and PD-L1 receptor was made by ELISA and flow cytometry. The cytotoxicity of the PD-L1 nanobody was tested by BHK-21, MDBK, and sheep kidney cells. The inhibitory effect on tumor model was verified. PD-L1 nanobody activated the macrophages was tested. Staphylococcus aureus was used to test the protective effect of the mice. Results: PD-L1 nanobody was successfully made and had a high affinity with PD-L1 receptor. PD-L1 has no cytotoxicity to many cells. It could decrease the tumor in weight. We also find PD-L1 nanobody activated the macrophages and protected the mouse from the challenge of Staphylococcus aureus. Conclusion: The PD-L1 nanobody improved the immunity of animals. It was verified that PD-L1 inhibited T cells may be always present in mice, and the activation of these cells improved the immunity and survival rate of mice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Immunotherapy: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Chuangfu Chen”
  • BylineArticles whose byline prints “Peng Wu”
  • BylineArticles whose byline prints “Jiao Jiao”